Pasadena, CACIK 7632124 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
319 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 9.27M | $9.96B | 7.5% | −1.53M | Reduced |
| 2 | Micron Technology Inc | 24.79M | $7.08B | 5.4% | −4.86M | Reduced |
| 3 | Alphabet Inc | 15.13M | $4.74B | 3.6% | −648.9K | Reduced |
| 4 | Microsoft Corp |
| 7.29M |
| $3.52B |
| 2.7% |
| −1.10M |
| Reduced |
| 5 | Kla Corp | 2.88M | $3.49B | 2.6% | −659.2K | Reduced |
| 6 | Astrazeneca PLC | 36.92M | $3.39B | 2.6% | −2.94M | Reduced |
| 7 | Nvidia Corporation | 17.23M | $3.21B | 2.4% | −1.54M | Reduced |
| 8 | Boston Scientific Corp | 31.10M | $2.97B | 2.2% | −2.01M | Reduced |
| 9 | Amgen Inc | 8.90M | $2.91B | 2.2% | −802.6K | Reduced |
| 10 | Tesla Inc | 6.32M | $2.84B | 2.2% | −304.7K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio